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The hypoxic fetus is at greater risk of cardiovascular demise during a challenge, but the reasons 1 
behind this are unknown. Clinically, progress has been hampered by the inability to study the human 2 
fetus non-invasively for long period of gestation.  Using experimental animals, there has also been an 3 
inability to induce gestational hypoxia while recording fetal cardiovascular function as the hypoxic 4 
pregnancy is occurring.  We use novel technology in sheep pregnancy that combines induction of 5 
controlled chronic hypoxia with simultaneous, wireless recording of blood pressure and blood flow 6 
signals from the fetus.  Here, we investigated the cardiovascular defense of the hypoxic fetus to 7 
superimposed acute hypotension.  Pregnant ewes carrying singleton fetuses surgically prepared with 8 
catheters and flow probes were randomly exposed to normoxia or chronic hypoxia from 121+1 days of 9 
gestation (term ~ 145 days). After 10 days of exposure, fetuses were subjected to acute hypotension via 10 
fetal nitroprusside intravenous infusion. Underlying in vivo mechanisms were explored by: a) analysing 11 
fetal cardiac and peripheral vasomotor baroreflex function; b) measuring the fetal plasma 12 
catecholamines; and c) establishing fetal femoral vasoconstrictor responses to the α1-adrenergic 13 
agonist phenylephrine.  Relative to controls, chronically hypoxic fetal sheep had reversed cardiac and 14 
impaired vasomotor baroreflex function, despite similar noradrenaline and greater adrenaline 15 
increments in plasma during hypotension.  Chronic hypoxia markedly diminished the fetal vasopressor 16 
responses to phenylephrine.  Therefore, we show that the chronically hypoxic fetus displays markedly 17 
different cardiovascular responses to acute hypotension, providing in vivo evidence of mechanisms 18 
linking its greater susceptibility to superimposed stress. 19 
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A reduction in fetal oxygenation or fetal hypoxia is one of the most common consequences of 22 
complicated pregnancy [1].  Studies have long established that the developing fetus in late gestation 23 
has robust cardiovascular compensatory mechanisms to withstand an acute episode of hypoxia [2, 3].  24 
By marked contrast, we know little about the effects of chronic hypoxia on the fetal cardiovascular 25 
system and even less during a superimposed challenge [4-6]. Important human clinical studies have 26 
reported that the growth restricted fetus displays significant alteration in cardiovascular structure and 27 
function.  However, whether these effects are mediated by chronic fetal hypoxia or other deficiencies 28 
has been difficult to isolate [7-9].   Experimental progress in the field of hypoxic pregnancy using 29 
animal models has been hampered for several reasons.  Most importantly, there has been an inability 30 
to induce hypoxia for long periods of gestation while recording cardiovascular data from the fetus.  31 
This gap of knowledge is of substantial clinical significance because the growth restricted fetus, 32 
presumed to be chronically hypoxic, is at a seven-fold risk of acute complications later in gestation.   33 
However, the reason behind this is completely unknown [10].  34 
  
The late gestation fetus has well described compensatory responses to alterations in blood pressure.  In 35 
response to acute hypotension, cardiac and vasomotor baroreflex responses are triggered [11,12]. 36 
Neural sympathetic outflow to arterioles increases fetal peripheral vascular resistance, and on the 37 
venous side, it promotes an increase in venous return to the fetal heart.  A fall in vagal outflow and an 38 
increase in sympathetic stimulation lead to cardiac sympathetic dominant effects. This increases fetal 39 
heart rate and ventricular contractility, both of which act in concert with the vasomotor responses to 40 
restore fetal arterial blood pressure back to baseline [11,12].  Fetal plasma catecholamines also 41 
increase in response to acute hypotension to maintain the neurally-triggered cardiovascular and 42 




Clinical studies of heart rate variability have provided evidence to support that the growth-restricted 44 
human fetus also displays a compromised autonomic control of cardiovascular function [14].  These 45 
studies suggest increased vulnerability to blood pressure instability, which may predispose these 46 
infants to systemic hypoperfusion, reducing oxygen and glucose delivery to the fetal brain [8].  47 
However, whether these effects occur because of chronic hypoxia during pregnancy, or how chronic 48 
hypoxia affects fetal cardiovascular defenses to alterations in blood pressure homeostasis and 49 
underlying mechanisms are completely unknown.   50 
 
We have created isobaric hypoxic chambers able to house pregnant ewes for long periods of gestation 51 
under highly controlled chronic hypoxic conditions. We have also created a wireless data acquisition 52 
system, the CamDAS, able to record in vivo cardiovascular data from singleton fetuses being carried 53 
by free-moving pregnant ewes within the hypoxic chambers [5, 6, 15].  Fetal cardiovascular data can 54 
then be transmitted by Bluetooth technology to a laptop outside the chamber (Fig. S1).  In this study, 55 
we have used this system to determine the in vivo the fetal cardiovascular responses to an episode of 56 
acute hypotension in the chronically hypoxic fetus.  Underlying mechanisms were explored adopting a 57 
three-pronged approach, by: a) constructing fetal in vivo cardiac and peripheral vasomotor baroreflex 58 
responses to acute hypotension; b) measuring the in vivo fetal plasma catecholamine response to acute 59 
hypotension; and c) establishing fetal in vivo pressor and peripheral vasopressor responses to 60 
exogenous bolus doses of the α1-adrenergic agonist phenylephrine.  Further, to investigate the capacity 61 
of the chronically hypoxic fetus to maintain perfusion of the brain during acute hypotension, we also 62 
calculated in vivo changes in oxygen and glucose delivery in the carotid and femoral vascular beds.  63 
The study tested the hypothesis that chronic hypoxia significantly impacts on the fetal cardiovascular 64 




Data availability.  The data underlying this article are available in the article. Any additional data 66 
required associated with this article can be made available from the corresponding author. 67 
 
Ethical approval 68 
All procedures were performed at The Barcroft Centre of the University of Cambridge under the UK 69 
Animals (Scientific Procedures) Act 1986 and were approved by the Ethical Review Board of the 70 
University of Cambridge. The experimental design was conducted in accordance with the ARRIVE 71 
guidelines. 72 
 
Surgical preparation 73 
Animals were instrumented as previously described [5, 6, 15, 16]. Briefly, 12 Welsh Mountain 74 
pregnant ewes carrying singleton male fetuses were surgically instrumented at 116 ± 1 days of 75 
gestational age (term is ca. 145 days).  Food but not water was withheld from the pregnant ewe for 76 
24 h prior to surgery. On the day of surgery, the ewe was transferred to a pre-operative room, where 77 
the neck fleece was clipped and anaesthesia was induced via injection of Alfaxan into the jugular vein 78 
(1.5-2.5 mg.kg-1 Alfaxalone; Jurox Ltd, Worcestershire, UK). The ewe was then placed on her back 79 
and intubated (Portex cuffed endotracheal tube; Smiths Medical International Ltd., Kent, UK).  80 
Anaesthesia was maintained by spontaneous inhalation of 1.5% isoflurane in O2 (2 L.min-1; IsoFlo; 81 
Abbott laboratories Ltd., Berkshire, UK) and the abdomen, flanks and medial surfaces of the hind 82 
limbs were shaved and cleaned. Antibiotics (30 mg.kg-1 I.M. procaine benzylpenicillin; Depocillin; 83 
Intervet UK Ltd, Milton Keynes, UK) and an analgesic agent (1.4 mg.kg-1 S.C. carprofen; Rimadyl; 84 
Pfizer Ltd, Kent, UK) were administered.   85 
 
Following transfer to the surgical theater, general anesthesia (1.5-2.0% isoflurane in 60:40 O2:N2O) 86 
was maintained using positive pressure ventilation in a non-rebreathing circuit (Datex-Ohmeda Ltd, 87 
Hatfield, Hertfordshire, UK). The animal was covered with sterile drapes and midline abdominal and 88 
uterine incisions were made to expose the fetal hind limbs, while minimizing loss of amniotic fluid, as 89 
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described previously [16-18]. On one side, fetal femoral arterial (i.d., 0.86 mm; o.d., 1.52 mm; 90 
Critchly Electrical Products, NSW, Australia) and venous (i.d., 0.56 mm; o.d., 0.96 mm) catheters 91 
were inserted.  Another catheter was anchored onto the fetal hind limb skin for recording of the 92 
reference amniotic pressure. A Transonic flow probe was positioned around the contra-lateral femoral 93 
artery (MC2RS-JSF-WC120-CS12-GCP, Transonic Systems Inc. Ithaca, New York). The uterine 94 
incision was closed in layers.  Through a second uterotomy, the fetal head was exteriorized.  The fetal 95 
carotid arteries were isolated and on one side a catheter was inserted.  A second Transonic flow probe 96 
(MC2RS-JSF-WC120-CS12-GCP) was positioned around the contra-lateral carotid artery [5, 17].  97 
The uterus was closed in layers and catheters and flow probe leads were exteriorized via keyhole 98 
incisions in the maternal flank.  Catheters were exteriorized on the ewe’s right side while the flow 99 
probe leads were exteriorized through the ewe’s left flank.  The maternal abdominal and skin incisions 100 
were then closed, as before [5, 6, 15-19].  The maternal femoral vessels on the right leg were then 101 
isolated.  A Teflon catheter (i.d.  1.0 mm, o.d. 1.6 mm, Altec, UK) was then inserted into the maternal 102 
femoral artery and placed in the descending aorta.  A maternal femoral venous catheter was inserted 103 
(i.d., 0.86 mm; o.d., 1.52 mm; Critchly Electrical Products, NSW, Australia).  These catheters were 104 
exteriorized through the same keyhole on the ewe’s right-side flank, and the skin incision was closed. 105 
 
While under general anesthesia, the ewe was then fitted with a bespoke jacket housing the wireless 106 
Cambridge Data Acquisition System (CamDAS, Maastricht Instruments, Maastricht, The Netherlands; 107 
[5, 6, 13]. The catheters were connected to pressure transducers (COBE; Argon Division, Maxxim 108 
Medical, Athens, TX, USA) within the pressure box housed in a pocket of the jacket on one side, and 109 
the flow probes leads were connected to the flow meter housed within a pocket of the jacket on the 110 
other side (Fig. S1).   Heart rate was triggered from the arterial blood pressure and flow pulsatile 111 
waveforms.  Recordings of fetal arterial blood pressure and heart rate, amniotic pressure, as well as 112 
carotid and femoral blood flow were then continuously transmitted wirelessly via Bluetooth 113 
technology onto a laptop computer and, from this moment on, recorded continuously until post-114 
mortem.  The ewe was recovered from anesthesia and extubated when spontaneous breathing returned 115 




Ewes were housed in individual pens in rooms with a 12h:12h/light:dark cycle where they had free 117 
access to hay and water and were fed concentrates twice daily (100 g sheep nuts no. 6; H & C Beart 118 
Ltd, Kings Lynn, UK). Antibiotics were administered daily to the ewe (0.20–0.25 mg kg−1 I.M. 119 
depocillin; Mycofarm, Cambridge, UK) and the fetus I.V. and into the amniotic cavity (600 mg in 2 120 
ml 0.9% NaCl, benzylpenicillin; Crystapen, Schering-Plough, Animal Health Division, Welwyn 121 
Garden City, UK). Generally, normal feeding patterns were restored within 24-48 h after surgery. 122 
Ewes were then randomly allocated to one of two experimental groups: normoxia (n=6) or chronic 123 
hypoxia (n=6).  124 
 
Chronic hypoxia protocol 125 
Ewes allocated to chronic hypoxia were housed in one of four bespoke isobaric hypoxic chambers at 126 
The Barcroft Centre of the University of Cambridge (Telstar Ace, Dewsbury, West Yorkshire, UK) [5, 127 
6, 15]. Ambient PO2, PCO2, humidity and temperature within each chamber were monitored via 128 
sensors and values recorded continuously (Fig. S1). Pregnancies assigned to the chronic hypoxia 129 
group were placed inside the chambers under normoxic conditions (11 L.sec-1 air, equating to 39.6 130 
m3.h-1) to acclimatize for 2 days.  On the 5th post-operative day at 121 ± 1 days of gestation, 131 
pregnancies assigned to chronic hypoxia were exposed to ca. 10% O2 by altering the incoming gas 132 
mixture to 5 L.sec-1 air: 6 L.sec-1 N2.  Air and nitrogen provision came from a specially designed air 133 
and nitrogen generating system (Domnick Hunter Gas Generation, Gateshead, Tyne & Wear, UK;[5]).  134 
Within the chambers, the induction of hypoxia was gradual, achieving 10% O2 over 24 h.  From this 135 
day on, chronic hypoxia was maintained at 10.0±0.05 %O2.  Fetal cardiovascular data transmitted 136 
wirelessly were recorded onto a laptop kept outside the hypoxic chamber laboratory. In this way, this 137 
system permitted continuous in vivo recording of fetal cardiovascular function without disturbing the 138 
animal’s environment and maintaining exposure to chronic hypoxia.   Pregnancies allocated to the 139 
normoxia group were housed in a barn in floor pens with the same floor area as the hypoxic chambers.  140 
Both the normoxia and chronic hypoxia groups of ewes were also fed daily the same bespoke 141 
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maintenance diet made up of concentrate pellets and hay (40g nuts/kg and 3g hay/kg; Manor Farm 142 
Feeds Ltd; Oakham, Leicestershire, UK) to facilitate the monitoring of maternal food intake. 143 
Daily blood sampling regimen and analysis 144 
Samples (0.3 ml) of maternal and fetal arterial blood were taken daily to determine health and 145 
measuring arterial blood gas, acid-base and metabolic status, as before [5, 6, 15-19].  Blood gas and 146 
acid base values were measured using an ABL5 blood gas analyser (Radiometer; Copenhagen, 147 
Denmark; maternal measurements corrected to 38oC, fetal measurements corrected to 39.5oC). Values 148 
for percentage saturation of hemoglobin with oxygen (Sat Hb) and for the concentration of 149 
hemoglobin in blood ([Hb]) were determined using a hemoximeter (OSM3; Radiometer).  Blood 150 
glucose and lactate concentrations were measured using an automated analyser (Yellow Springs 2300 151 
Stat Plus Glucose/Lactate Analyser; YSI Ltd., Farnborough, UK). Values for hematocrit were 152 
obtained in duplicate using a microhematocrit centrifuge (Hawksley, UK).  153 
 
Pressor and peripheral vasopressor responses to the α1-adrenergic agonist phenylephrine 154 
On the 10th day of exposure to normoxia or chronic hypoxia, fetuses were treated i.v. with bolus doses 155 
of phenylephrine (5, 12.5, 25, 37.5 and 50 μg; Sigma UK) administered in random order (Fig. S2). 156 
The dose regimen was adapted from previous experiments in our laboratory that resulted in dose-157 
dependent changes in cardiovascular function in late gestation fetal sheep [19].  For chronic hypoxic 158 
pregnancies, the fetal phenylephrine doses were administered while the ewes remained inside the 159 
hypoxic chambers.  For normoxic pregnancies, the fetal phenylephrine doses were administered while 160 
the ewes were in a metabolic crate, inside a laboratory.  Doses were given in random order when 161 
cardiovascular variables were at stable baseline. At least 10 min between doses were allowed for 162 
cardiovascular data to return to baseline.  Maximal changes from baseline for fetal arterial blood 163 
pressure, fetal heart rate, femoral blood flow and femoral vascular resistance were then calculated to 164 
each dose of phenylephrine, as before [19, 20].  Cardiovascular function returned to baseline 165 





Acute hypotension challenge 167 
The day after dose responses, fetuses were exposed to an acute hypotension challenge (Fig. S2).  This 168 
consisted of 10 minutes of baseline, 10 minutes of hypotension and 10 minutes of recovery.  For 169 
chronic hypoxic pregnancies, the acute hypotension challenge occurred while inside the hypoxic 170 
chambers.  For normoxic pregnancies, the acute hypotension challenge occurred while the animal was 171 
in a metabolic crate, inside a laboratory.  Acute hypotension was induced via intravenous infusion of 172 
sodium nitroprusside (SNP; Sigma, UK, 50μg kg-1 min-1). The dosing regimen of nitroprusside was 173 
adapted from past experiments in our laboratory, which achieved a significant reduction in arterial 174 
blood pressure that triggered compensatory cardiovascular responses [20-22]. 175 
 
Cardiac and peripheral vasomotor baroreflex responses to acute hypotension 176 
Minute by minute average values for fetal arterial blood pressure, fetal heart rate and femoral blood 177 
were downloaded continuously throughout the acute hypotension experimental protocol and imported 178 
into an Excel spreadsheet. Minute by minute average values for fetal femoral vascular resistance were 179 
then calculated using Ohm’s approximation and dividing arterial blood pressure (corrected for 180 
amniotic pressure) by femoral blood flow, as before [16-19].  Baroreflex analysis was performed by 181 
plotting the heart rate against mean arterial blood pressure for each fetus in response to phenylephrine 182 
and nitroprusside.  The slope of the linear relationship between changes in heart rate and in arterial 183 
blood pressure in response to phenylephrine was used to determine the vagal dominant contribution to 184 
the fetal cardiac baroreflex response [22].  185 
 
Fetal plasma catecholamine response to acute hypotension  186 
Paired fetal carotid and femoral arterial blood samples (4 ml) were taken during baseline (-10, -5 min), 187 
during acute hypotension (+5, +10 min), and 10 minutes after recovery from hypotension (+20 min). 188 
These samples were used to determine blood gas and metabolic status, as before, and for analysis of 189 
fetal plasma noradrenaline and adrenaline concentrations (femoral sample only).  For the 190 
catecholamine assay, blood was dispensed into EDTA-treated tubes, centrifuged for plasma extraction 191 
and frozen at -80oC until analysis within 3 months of collection, as described before [23, 24].  An 192 
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ELISA kit was used to determine the concentration of fetal plasma noradrenaline and adrenaline, in 193 
duplicate, following the manufacturer’s instructions (KA1877, Abnova, Taipei, Germany).  For 194 
noradrenaline, the inter- and intra-assay coefficients of variation were 12.8% and 14.6%, respectively, 195 
and the lower limit of detection was 0.05 ng.ml-1. For adrenaline, the inter- and intra-assay coefficients 196 
of variation were 9.7% and 15.7%, respectively, and the lower limit of detection was 0.01 ng.ml-1.   197 
 
Oxygen and glucose delivery in the carotid and femoral vascular beds during acute hypotension  
Fetal arterial blood oxygen content (CaO2) and regional changes in oxygen delivery (O2,del) were 198 
calculated according to Equations 1 and 2, as before [5, 25]:  199 
 
Equation 1. CaO2 (mmol.L-1)  =  [[Hb] x Sat Hb/100]x0.62 200 
Equation 2. O2del, (µmol.min-1) =  CaO2 x blood flow (ml.min-1) 201 
 
Where [Hb] (g.dl-1) is the blood concentration of haemoglobin, Sat Hb (%) is the percentage oxygen 202 
saturation of haemoglobin and where 1 molecule of Hb (M.W. 64,450) binds 4 molecules of oxygen. 203 
The contribution of oxygen dissolved in plasma is regarded as negligible [26]. Values for oxygen and 204 
for glucose delivery to the fetal carotid and femoral vascular beds were then calculated using 205 
Equations 3 and 4, respectively: 206 
 
Equation 3. Oxygen delivery (mmol.min-1) = O2 content (mmol.ml-1) x appropriate flow (ml.min-1) 207 
Equation 4. Glucose delivery (mmol.min-1) = [Glucose] (mmol.ml-1) x appropriate flow (ml.min-1) 208 
 
After the end all experiments, all animals were transferred to the post-mortem laboratory and 209 
humanely killed by overdose of sodium pentobarbitone (0.4 ml.kg−1 IV Pentoject; Animal Ltd, York, 210 






 Statistical analysis 212 
Appropriate power calculations derived from previous data sets were performed to determine the 213 
minimum sample size required to achieve statistical significance [16-19, 23-27].   The experiments 214 
were completed within one experimental season and scientists measuring outcomes were blinded to 215 
treatments.  All data are expressed as mean ± SEM.  Cardiovascular, endocrine and metabolic data 216 
were analysed using two-way ANOVA, with repeated measures where appropriate or with the 217 
Student’s t test for unpaired data.  When a significant interaction between main effects occurred, 218 
differences were compared using the Tukey or Student Newman Keuls post hoc tests.  For all 219 




Maternal and fetal health during baseline and exposure to chronic hypoxia 221 
Basal maternal daily food consumption was not different between groups, and exposure to chronic 222 
hypoxia of this duration did not affect maternal food intake [5] or fetal body weight when measured at 223 
post mortem (Normoxia: 3.05±0.30 vs. Chronic hypoxia: 3.21±0.30 kg, P=NS). 224 
 
Basal values for maternal arterial blood gas, acid-base and metabolic status were not different 225 
between groups and they were within the normal range for Welsh Mountain ewes [28]; Fig. 1A).  226 
Ewes exposed to chronic hypoxia had a significant reduction in the partial pressure of arterial oxygen 227 
(mean±SEM: 106.4 ± 3.7 to 47.3 ± 1.9 mmHg) and in arterial oxygen saturation (mean±SEM: 78.6 ± 228 
5.6%) compared to controls (100.6 ± 0.5%) and their own baseline (P<0.05; Fig. 1A). Further, ewes 229 
exposed to chronic hypoxia had significantly elevated hematocrit by the end of exposure 230 
(mean±SEM: 33.7 ± 1.0 vs. 27.9 ± 01.5%).  There was no significant change between groups in 231 
maternal arterial pH or partial pressure of arterial carbon dioxide (Fig. 1A).  232 
 
Basal values for fetal arterial blood gas, acid-base and metabolic status were similar between groups 233 
and were within the normal range for Welsh Mountain singleton sheep fetuses at this stage of 234 
gestation [16-19, 29]; Fig. 1B). Fetuses exposed to chronic hypoxia had a significant reduction from 235 
baseline in the partial pressure of arterial oxygen (mean±SEM:  20.8 ± 0.7 to 12.3 ± 1.0 mmHg) and 236 
arterial oxygen saturation (mean±SEM: 60.4 ± 2.1 to 34.6 ± 2.7 %, P<0.05, Fig. 1B).  Fetuses 237 
exposed to chronic hypoxia also had significantly elevated hematocrit by the end of exposure 238 
(mean±SEM: 36.6 ± 1.5 vs. 28.2 ± 2.0, P<0.05).  There was no change between groups in fetal arterial 239 
pH, however chronically hypoxic fetuses showed a significant fall in the partial pressure of arterial 240 
carbon dioxide (Fig. 1B). Changes in values for fetal arterial blood pressure, fetal heart rate, fetal 241 
carotid blood flow and fetal femoral blood flow during normoxia or chronic hypoxia have previously 242 
been reported [5].  In brief, relative to controls, fetuses which were chronically hypoxic showed a 243 
smaller increase in arterial blood pressure and a delayed fall in fetal heart rate with advancing 244 
13 
 
gestation.  Further, measurement of blood flow in the carotid and femoral circulation revealed 245 
sustained increases during the period of chronic hypoxia [5]. 246 
 
Fetal basal blood gas, acid-base status and cardiovascular function prior to acute experiments 247 
On day 10 of exposure, prior to the phenylephrine dose response experiment, chronically hypoxic 248 
fetuses remained with significantly lower values for PaO2, PaCO2 and SatHb, and significantly 249 
elevated values for hematocrit relative to normoxic fetuses (Table S1).  Chronically hypoxic fetuses 250 
also had significantly reduced basal femoral blood flow and heart rate compared to normoxic fetuses 251 
(P<0.05; Table S1). Basal values for other fetal metabolic or cardiovascular variables prior to the 252 
phenylephrine dose response experiment were not different between groups (Table S1).  253 
 
Pressor and femoral vasopressor responses to the α1-adrenergic agonist phenylephrine 254 
In normoxic fetuses, exogenous intravenous treatment with bolus doses of phenylephrine lead to dose-255 
dependent increments from baseline in fetal arterial blood pressure and in fetal femoral vascular 256 
resistance, and in dose-dependent decrements from baseline in fetal heart rate and in fetal femoral 257 
blood flow (Fig. 2A-D). In chronically hypoxic fetuses, the increments in fetal femoral vascular 258 
resistance were markedly diminished (Fig. 2D). In particular, chronically hypoxic fetuses had 259 
significant blunting of the femoral vascular resistance response to higher doses of phenylephrine 260 
(25g H:1.5 ± 0.4 vs. N: 14.9 ± 6.0 and 50 g H:7.5 ± 3.2 vs. N:36.5 ± 10.0 mmHg.(mL.min-1) -1; 261 
P<0.05, Fig. 2D).   262 
 
Fetal cardiovascular response to an acute hypotension and fetal cardiac baroreflex function 263 
In normoxic fetuses, nitroprusside infusion resulted in a significant fall in arterial blood pressure from 264 
baseline (Table S1 and Fig. 3A). The decrease in arterial blood pressure ( from baseline -26.3 ± 5.2 265 
mmHg) was accompanied by a significant increase in fetal heart rate (Table S1 and Fig. 3B,  from 266 
baseline 33.8 ± 9.4 bpm) and in fetal femoral vascular resistance (Fig. 3C,  from baseline 0.33 ± 0.2 267 
mmHg.(mL.min-1)-1; both P<0.05). The increase in fetal femoral vascular resistance occurred in 268 
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parallel with a return in fetal arterial blood pressure towards baseline.  During recovery, while femoral 269 
vascular resistance continued to increase, fetal arterial blood pressure and fetal heart rate returned to 270 
basal levels in normoxic fetuses (Fig. 3). In marked contrast, in chronically hypoxic fetuses, although 271 
the fall in fetal arterial blood pressure was similar ( baseline -24.0 ± 2.5 mmHg), in these fetuses 272 
fetal heart rate did not increase but decreased (Table S1 and Fig. 3B), and the increase in femoral 273 
vascular resistance during acute hypotension and recovery was significantly diminished compared to 274 
normoxic fetuses (Fig. 3C). During recovery, chronically hypoxic fetus failed to return fetal arterial 275 
blood pressure to basal levels, maintaining a significantly reduced arterial blood pressure compared to 276 
normoxic fetuses by the end of the experiment ( from baseline -2.9 ± 1.8 vs. 2.0 ± 2.0 mmHg, 277 
P<0.05; Fig.3A).  The arterial blood pressure-heart rate relationship in normoxic fetuses showed a 278 
normal cardiac baroreflex function with a traditional reverse sigmoidal plot for cardiac autonomic 279 
stimulation (Fig. 3D).  In marked contrast, the shape of the sympathetic quadrant of the cardiac 280 
baroreflex relationship depicting the changes in heart rate in response to decrements in arterial blood 281 
pressure induced by fetal treatment with nitroprusside was reversed in chronically hypoxic fetuses 282 
(Fig. 3D).  Calculation of the slope of the linear plot between changes in fetal arterial blood pressure 283 
and heart rate in response to phenylephrine in the vagal quadrant component of the cardiac baroreflex 284 
revealed a steeper relationship in chronically hypoxic fetuses relative to controls (Fig. 3E and 3F).        285 
 
Fetal plasma catecholamine response to acute hypotension 286 
Exposure to chronic hypoxia did not affect fetal plasma catecholamine concentrations during 287 
baseline.  Therefore, values for fetal basal plasma catecholamines concentrations prior to the acute 288 
hypotension experiment were not significantly different between normoxic (Noradrenaline: 841.8 ± 289 
207; Adrenaline 66.4 ± 4 pg.mL-1) and chronically hypoxic (Noradrenaline:1170 ± 296; Adrenaline 290 
88.6 ± 14 pg.mL-1) fetuses. During acute hypotension, fetal plasma noradrenaline concentrations 291 
increased in a similar manner in both normoxic ( baseline 2229 ± 486 pg/mL) and chronically 292 
hypoxic ( baseline 1403 ± 874 pg/mL; Fig. 4A) fetuses.  In contrast, the increase in fetal plasma 293 
adrenaline concentrations during acute hypotension was significantly enhanced in chronically hypoxic 294 
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fetuses compared with normoxic controls ( baseline H:711 ± 329 vs. N:310 ± 77 pg/mL, P<0.05; 295 
Fig. 4B).  Both noradrenaline and adrenaline concentrations returned towards baseline levels in all 296 
fetuses during the recovery period.  297 
  
Changes in fetal oxygen and glucose delivery in the carotid and femoral vascular beds  
During acute hypotension, fetal pH and arterial blood gases were maintained at basal levels in both 298 
normoxic and chronically hypoxic fetuses (Fig. S3).   During acute hypotension, carotid blood flow 299 
was better maintained than femoral blood flow in both groups of fetuses.  However, there were no 300 
significant differences from baseline or between groups in either carotid or femoral blood flow (Fig. 301 
5A and 5B). During acute hypotension, oxygen content was similar in both carotid and femoral 302 
vascular beds in chronically hypoxic fetuses compared with normoxic fetuses (Fig. 5A and 5B). In 303 
contrast, during acute hypotension, blood glucose concentrations increased in both normoxic and 304 
chronically hypoxic fetuses, although this only reached significance in both groups in the femoral and 305 
not carotid vascular bed (Fig. 5A and 5B). During acute hypotension, oxygen and glucose delivery to 306 
both carotid and femoral vascular beds was maintained in normoxic and chronically hypoxic fetuses 307 
(Fig. 5A and 5B). When the ratio of oxygen and glucose delivery in the carotid relative to the femoral 308 
vascular bed was calculated, both normoxic and chronically hypoxic fetuses showed a significant 309 
increase from baseline of similar magnitude in this ratio for both oxygen and glucose delivery during 310 
acute hypotension (Fig. 5A and 5B).  During recovery, blood glucose in the femoral vascular bed 311 
remained similarly elevated from baseline in normoxic and chronically hypoxic fetuses (Fig. 5B), and 312 
the ratio of oxygen and glucose delivery in the carotid relative to the femoral vascular bed returned 313 











These data show that chronic hypoxia has a significant impact on the fetal cardiovascular defense to a 315 
superimposed acute hypotensive challenge, supporting the hypothesis tested in this study.  Markedly 316 
impaired baroreflex responses, vagal dominant regulation of the fetal heart during acute hypotension 317 
and diminished constrictor reactivity in the peripheral vasculature to α1-adrenergic stimulation provide 318 
in vivo evidence of underlying mechanisms explaining the altered cardiovascular responses in the 319 
chronically hypoxic fetus.  However, the plasma catecholamine response to acute hypotension was not 320 
diminished; in fact, the fetal plasma adrenaline response to acute hypotensive stress was markedly 321 
enhanced in the chronically hypoxic relative to the normoxic fetus. 322 
 
Chronic hypoxia induces the activation of the hypoxia inducible factor (HIF), which regulates the 323 
expression of hundreds of genes including erythropoietin or EPO, which enhances red blood cell 324 
production, and this effect is measured by an increase in haematocrit [30].  We show that exposure 325 
pregnant ewes to ca. 10% O2 for 10 days led to an increase in maternal and fetal hematocrit levels, 326 
confirming HIF activation.  This level of chronic hypoxia was chosen as it reduces the fetal PaO2 in 327 
the descending aorta from normal values of ca. 20 mmHg to values of 12-14 mmHg.  This magnitude 328 
of fetal chronic hypoxia is important because such fetal PaO2 values are similar to those measured by 329 
cordocentesis in human fetuses affected by growth restriction, as reported in pioneering clinical 330 
studies [31-33].  In the present study, there was also a reduction in fetal PaCO2 in response to chronic 331 
hypoxia.  This may indicate alterations in the rate of fetal metabolism in the presence of hypoxia, 332 
minimizing fetal oxygen consumption with a consequent fall in fetal CO2 production [5].  333 
Importantly, this level of maternal hypoxia did not affect maternal food intake. Therefore, the adverse 334 
effects on the fetal cardiovascular capacity to respond to acute hypotension measured in the present 335 
study are those of isolated chronic hypoxia, of levels that are human clinically relevant. 336 
 
To address mechanisms explaining the weaker peripheral vasoconstrictor response and the reversed 337 
heart rate response to acute hypotension in the chronically hypoxic fetus, we determined fetal in vivo 338 
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pressor and femoral vasopressor responses to exogenous bolus doses of the 1-adrenergic receptor 339 
agonist phenylephrine, we constructed cardiac baroreflex function curves and we measured the fetal 340 
in vivo endocrine catecholamine response during the acute hypotension challenge. The dose-response 341 
experiment in the present study revealed that femoral vasopressor responses to 1-adrenergic receptor 342 
stimulation are markedly blunted in the chronically hypoxic fetus.  The cardiac baroreflex analysis 343 
showed an absent sympathetic component altogether with enhanced vagal sensitivity regulating 344 
cardiac function. Measurement of plasma catecholamines during the acute hypotension experiment 345 
further revealed that the fetal plasma catecholamine response is not suppressed; rather the fetal plasma 346 
adrenaline response to acute hypotension is enhanced in the chronically hypoxic fetus compared to the 347 
normoxic fetus.  Combined, therefore, these data show that reduced plasma catecholamine responses 348 
could not explain the cardiovascular deficits to acute hypotension. Rather, chronic hypoxia impaired 349 
fetal femoral vasopressor responses mediated via α1-adrenergic receptor stimulation and switched the 350 
balance of the autonomic regulation of cardiac function towards vagal dominance during acute 351 
hypotension.  Clinically, fetal hypotension can be linked with profound fetal hypoxia [34].  Therefore, 352 
one could argue that the fall in heart rate during acute hypotension in the chronically hypoxic fetus 353 
may result from carotid chemoreceptor reflex activation [3,17] rather than a failed cardiac baroreflex.  354 
However, this idea is not supported, since the arterial blood gas data during acute hypotension in the 355 
present study show that PaO2 was not reduced from baseline during the acute hypotension challenge 356 
in the chronically hypoxic fetus. 357 
 
In the human fetus, autonomic function can be assessed non-invasively by measurement of fetal heart 358 
rate variability (FHRV).  Several investigators have reported that reduced FHRV may be associated 359 
with fetal growth restriction and fetal compromise [14, 15, 35, 36].  Therefore, computerized 360 
cardiotocography (cCTG) examination, is recommended for antenatal surveillance of human fetuses 361 
with suspected placental insufficiency and chronic fetal hypoxia [37].  A recent study in our 362 
laboratory using this model of chronic fetal hypoxia in sheep reported that FHRV is reduced by 363 
chronic hypoxia, predominantly due to dysregulation of the sympathetic control of the fetal heart [15]. 364 
18 
 
Another comprehensive study in sheep reported that chronic hypoxia increased binding of angiotensin 365 
receptors in the fetal brainstem, and this was associated with a fall in spontaneous baroreflex 366 
sensitivity and evidence of vagal dominant regulation of heart rate [38].  Finally, an elegant series of 367 
studies using long-term exposure of ovine pregnancies to the chronic hypobaric hypoxia of life at high 368 
altitude have reported impaired signalling in both 1- and 1-adrenergic receptor pathways in the heart 369 
and vasculature, respectively, in chronically hypoxic fetal sheep [39, 40].   Combined, data from all 370 
these studies are consistent with the findings reported in the present investigation, indicating both 371 
alterations in the central autonomic regulation of cardiovascular function as well as changes in the 372 
reactivity of cardiovascular target organs to noradrenergic stimulation in the chronically hypoxic 373 
fetus.  Since several clinical studies have reported that the growth restricted human infant displays 374 
compromised autonomic cardiovascular control as well as weak defenses to acute challenges [8, 10], 375 
data in the present study support that these adverse effects in the growth restricted fetus are likely to 376 
be due to those induced by chronic fetal hypoxia alone.  Reduction in indices of FHRV as a result of 377 
sympathetic suppression may therefore predict chronically hypoxic fetuses at increased risk of birth 378 
asphyxia during acute events and at increased risk of neonatal morbidity and mortality in humans.  A 379 
reduction in overall FHRV may therefore provide a clinical biomarker indicating that autonomic 380 
dysregulation of fetal heart rate control has taken place in a fetus with suspected uteroplacental 381 
compromise. 382 
 
Human clinical studies have also associated reductions in FHRV in growth restricted pregnancies with 383 
increased risk of blood pressure instability, predisposing the human infant to systemic hypoperfusion, 384 
thereby reducing oxygen and glucose delivery to the fetal brain [8, 41].  For this reason, it was of 385 
interest to measure changes in oxygen and glucose delivery to the fetal carotid and femoral vascular 386 
beds during acute hypotension in the present study.  During acute stress, the fetal circulatory response 387 
redistributes the delivery of nutrients away from peripheral and towards essential vascular beds, such 388 
as those perfusing the brain [2, 3].  This brain sparing defense can be illustrated by calculating the 389 
ratio of oxygen and glucose delivery in the carotid relative to the femoral vascular beds during the 390 
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episode of acute stress [3, 5].  Data in the present study show that maintenance of oxygen and glucose 391 
delivery towards the fetal brain was not altered in the chronically hypoxic relative to normoxic fetus.    392 
 
In fetal life, the origin of the increase in both plasma adrenaline and noradrenaline during acute 393 
stressful conditions is the adrenal gland, rather than from sympathetic neuronal spill-over [42]. The 394 
enhanced plasma adrenaline response to acute hypotensive stress in the chronically hypoxic fetus in 395 
the present study is consistent with reports of an enhanced catecholamines response to acute hypoxic 396 
stress in chronically hypoxic fetal sheep [43].  Possible mechanisms driving an enhanced plasma 397 
adrenaline response to acute stress in the chronically hypoxic fetus may include a sensitized activation 398 
of the splanchnic nerve, since a major component of the increase in total catecholamine output from 399 
the fetal adrenal gland during acute stress is mediated via stimulation of the splanchnic nerves [42, 400 
44]. In addition, chronic hypoxia may affect the expression and activity of catecholamine synthetic 401 
enzymes tyrosine hydroxylase (TH) and phenylethanolamine N-methyltransferase (PNMT) (see [45]). 402 
The functional significance of the increase in plasma adrenaline in response to acute stress in the late 403 
gestation fetus is to inhibit insulin while stimulating glucagon, decrease glucose uptake by the fetal 404 
tissues and mobilize the increased blood glucose levels, prioritizing glucose delivery to essential 405 
organs like the fetal brain [46, 47]. 406 
 
It is of interest that despite a weaker cardiac and vasomotor baroreflex response to acute hypotension 407 
and impaired peripheral vascular reactivity to -adrenergic agonists, oxygen and glucose delivery to 408 
the fetal brain was maintained during acute hypotensive stress in the chronically hypoxic fetus.  It is 409 
possible that the enhanced fetal plasma adrenaline response in the chronically hypoxic fetus is an 410 
adaptive response, attempting to compensate for the poor cardiac sympathetic response while ensuring 411 
adequate delivery of glucose to the fetal brain during acute hypotension.  Therefore, the chronically 412 
hypoxic fetus may adopt alternative defense mechanisms to maintain brain sparing, at least in 413 
response to short term challenges in blood pressure homeostasis.  The magnitude of the fall in fetal 414 
arterial blood pressure during acute hypotension in the present study is similar or even less severe 415 
than what might be expected to be induced by single or repeated umbilical cord compression in the 416 
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clinical setting (see [34]).  How the chronically hypoxic fetus would respond to episodes of similar or 417 
alternative forms of stress of greater severity and/or longer duration and/or increased frequency is 418 
clearly a rich avenue of future research. 419 
 
There are several advantages and limitations of using sheep as the species of choice for such 420 
investigations in fetal cardiovascular physiology. An advantage is that sheep and humans share more 421 
similar prenatal developmental milestones of cardiovascular anatomy and physiology, in contrast to 422 
rodents which are born highly immature [48, 49].  In addition, the chronically instrumented fetal 423 
sheep preparation is the only established animal model that permits surgical implantation of catheters 424 
and flow probes for prolonged cardiovascular recording, yielding a physiologically robust, long-term 425 
preparation.  This level of insight does not exist for any other species.  Further, sheep and humans 426 
give birth primarily to singleton or twin offspring, in contrast to rodents and pigs that give birth to 427 
litters.  Hence, the maternal metabolic investment in the pregnancy is likely more similar between 428 
sheep and humans, relative to many other species, as multiple pregnancies increase the maternal basal 429 
metabolic rate [50].  In contrast, there are important limitations of the current study.  One obvious one 430 
is cost of using sheep for long term studies relative to using rodents.  The study design therefore 431 
controlled for, but it did not address sex differences.  Limitations in cost also reduces the number of 432 
animals per group, thereby increasing the number of experimental comparisons that are likely 433 
underpowered for statistical analysis.  434 
 
In conclusion, this study has permitted in vivo continuous recording of cardiovascular function in 435 
fetuses undergoing highly controlled chronic hypoxia and exposed to an acute secondary stressor, 436 
highlighting the strength of the conceptual advance to the field of study.   We show that the 437 
chronically hypoxic fetus displays markedly altered cardiovascular responses to an acute hypotensive 438 
stress.  Such effects may explain the explain the well-known greater susceptibility of the human 439 






This study shows what happens when a chronically hypoxic fetus is exposed to a further stressor in 441 
utero. Clinically, such a situation could arise in human pregnancy when a growth-restricted fetus is 442 
exposed to excessive uterine contractions in labor, acute cord compression or an acute placental 443 
hemorrhage event. In the clinic, this can lead to acute decompensation of fetal cardiovascular 444 
defenses, failure to maintain fetal arterial blood pressure, culminating in severe hypoxic ischemic 445 
encephalopathy with subsequent fetal brain damage. This situation is difficult to recreate in vivo in an 446 
experimental animal model.  Here, we have exploited novel terchnology recently available to induce a 447 
controlled period of chonic hypoxia in sheep pregnancy at levels of human clinical relevance and 448 
investigated the effects of a superimposed second hit in the form of an acute hypotensive challenge.  449 
We show that chronic hypoxia has a significant effect on the fetal cardiovascular defense responses to 450 
a second hit.  This provides in vivo evidence of mechanisms linking the greater susceptibility of the 451 
chronically hypoxic fetus to superimposed stress, and adds to the body of evidence behind the cause 452 
of brain damage after fetal growth restriction. Antenatal and intrapartum periods of hypoxia leading to 453 
collapse of fetal cardiovascular defenses are important causes of fetal brain damage and common 454 
grounds for litigation in many national health systems.  Therefore, the data reported in this manuscript 455 
may help to diagnose the compromised fetus where uteroplacental dysfunction is suspected to try and 456 
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Novelty and Significance 
What is new? 
 
• The growth restricted fetus, presumed to be chronically hypoxic, is at a seven-fold risk of 
acute complications later in gestation.   However, the reason behind this is unknown. 
• We show that chronic hypoxia substantially alters the fetal cardiovascular defense to a second 
hit, providing an explanation for this well established vulnerability. 
  
What is relevant? 
• Adverse conditions during pregnancy can trigger a fetal origin of increased disease risk in the 
offspring.  This study shows that chronic hypoxia, one of the most common complications in 
human pregnancy, substantially affects fetal defense mechanisms, increasing a future risk of 
cardiovascular and neurodevelopmental dysfunction after birth.   
 
Summary 






Figure 1. Maternal and fetal blood gases during chronic hypoxia. Values are mean±S.E.M. for the 469 
maternal (A) and fetal (B) arterial blood gas status in sheep undergoing normoxic ( , n=6) or chronic 470 
hypoxic ( , n=6) pregnancy. pH, arterial pH; PaCO2, arterial CO2 partial pressure; Htc, hematocrit; 471 
PaO2, arterial O2 partial pressure; Sat [Hb], percentage saturation of hemoglobin.  The results of the 472 
two-way RM ANOVA for main effects and interactions are shown.  When a significant (P<0.05) 473 
interaction between main effects occurred, differences were compared using the Tukey post hoc test. * 474 
indicates a significant effect of time compared with baseline; † indicates a significant effect of 475 
treatment compared with normoxic pregnancy. 476 
 
Figure 2. Pressor and femoral vasopressor responses to phenylephrine in the chronically 477 
hypoxic fetus. Values are the mean ± SEM for the change from baseline in fetal arterial blood 478 
pressure (A), heart rate (B), femoral blood flow (C) and femoral vascular resistance (D) in response to 479 
increasing doses of phenylephrine (5, 12.5, 25 and 50 μg) in normoxic (open bars, n=6) and 480 
chronically hypoxic (grey bars, n=6) fetuses. The results of the two-way RM ANOVA for main 481 
effects and interactions are shown.  When a significant (P<0.05) interaction between main effects 482 
occurred, differences were compared using the Newman–Keuls post hoc test. Different letters indicate 483 
a significant effect of dose within groups (normoxic a-c, hypoxic x-z; † indicates a significant effect of 484 
treatment compared with normoxic pregnancy.   485 
 
Figure 3. Cardiovascular responses to acute hypotension and cardiac baroreflex function in the 486 
chronically hypoxic fetus. Panels A-C show the mean±S.E.M. values for the change from baseline in 487 
arterial blood pressure (A), heart rate (B) and femoral vascular resistance (C) in normoxic ( , n=6) or 488 
chronically hypoxic ( , n=6) fetuses during the acute hypotension experiment.  Acute hypotension 489 
(dashed box) was induced for 10 minutes by fetal i.v. infusion with sodium nitroprusside (2.5 490 
mg/kg/min). Panels D-F show an analysis of cardiac baroreflex function.  The fetal arterial blood 491 
pressure-heart rate relationship was constructed by plotting the change from baseline in both variables 492 
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mean±S.E.M. (x and y) in response to sodium nitroprusside or to fetal treatment with increasing doses 493 
of phenylephrine (D).  The vagal dominant component of the cardiac baroreflex is expanded in Panel 494 
E (mean±S.E.M. for x and y). Panel F show the mean±S.E.M. values for an analysis of slopes for the 495 
vagal dominant component of the cardiac baroreflex. The results of the two-way RM ANOVA for 496 
main effects and interactions for A-C are shown.  When a significant (P<0.05) interaction between 497 
main effects occurred, differences were compared using the Tukey post hoc test. * indicates a 498 
significant effect of time compared with baseline; † indicates a significant effect of treatment 499 
compared with normoxic pregnancy. Groups in Panel F were compared by the Student’s t test for 500 
unpaired data. † indicates a significant effect of treatment compared with normoxic pregnancy. 501 
 
Figure 4. Plasma catecholamine response to acute hypotension in the chronically hypoxic fetus. 502 
Values are mean±S.E.M. for the change from baseline in noradrenaline (A) and adrenaline (B) in 503 
normoxic ( , n=6) or chronically hypoxic ( , n=6) fetuses during the acute hypotension experiment.  504 
Acute hypotension (dashed box) was induced for 10 minutes by fetal i.v. infusion with SNP (2.5 505 
mg/kg/min).  Plasma samples were taken during baseline (-10 and -5 min), during hypotension (+5 506 
and +10 min) and after 10 min of recovery (+20 min).  The results of the two-way RM ANOVA for 507 
main effects and interactions are shown.  When a significant (P<0.05) interaction between main 508 
effects occurred, differences were compared using the Tukey post hoc test. * indicates a significant 509 
effect of time compared with baseline; † indicates a significant effect of treatment compared with 510 
normoxic pregnancy. 511 
 
Figure 5. Changes in oxygen and glucose delivery in the carotid and femoral vascular beds 512 
during acute hypotension in the chronically hypoxic fetus.  Values are mean±S.E.M. for blood 513 
flow, oxygen content, blood glucose concentration, oxygen delivery and glucose delivery in the 514 
carotid (A) and femoral (B) vascular beds.  The ratio of oxygen and glucose delivery in the carotid 515 
relative to the femoral vascular beds is also calculated.  Groups are normoxic ( , n=6) or chronically 516 
hypoxic ( , n=6) fetuses. Acute hypotension (dashed box) was induced for 10 minutes by fetal i.v. 517 
infusion with SNP (2.5 mg/kg/min). The results of the two-way RM ANOVA for main effects and 518 
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interactions are shown.  There no significant interactions between main effects. 519 
 
Figure 6. Summary Figure.  During acute hypotension, the normoxic fetus in healthy pregnancy 520 
activates cardiac and vasomotor baroreflex responses to restore blood pressure homeostasis.  This 521 
involves baroreflex alteration in autonomic outflow via the brainstem. Increased sympathetic outflow 522 
coupled with vagal withdrawal to the heart promotes cardiac sympathetic dominant effects, which 523 
increase heart rate and contractility via 1-adrenergic receptor pathways. Enhanced sympathetic 524 
outflow to the arterioles increases peripheral vascular resistance via a1-adrenergic receptor pathways. 525 
Enhanced sympathetic outflow to the veins increases venous return via 1-adrenergic receptor 526 
pathways.  The increase in venous return, coupled with increased myocardial contractility lead to an 527 
increase in cardiac output.  The increase in peripheral vascular resistance together with the increase in 528 
cardiac output restore fetal arterial blood pressure back to baseline.  In the chronically hypoxic fetus, 529 
baroreflex-induced increases in heart rate do not occur.  Instead, there is a fall in heart rate due to 530 
increased vagal dominant effects.  In addition, responsiveness to 1-adrenergic receptor pathway 531 
stimulation is blunted in the peripheral vasculature.  Combined, these effects of chronic hypoxia on 532 
the heart and circulation weaken the fetal cardiovascular defence to acute hypotension in the 533 
chronically hypoxic fetus, providing a mechanistic link underlying its greater susceptibility to a 534 
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Table S1. Basal fetal arterial blood gas, metabolic status and cardiovascular function prior to acute experiments. Values are mean±S.E.M. for fetal 
arterial blood pH, arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), percentage saturation of haemoglobin with 
oxygen (Sat[Hb]), blood glucose and lactate concentrations, arterial blood pressure (BP), heart rate (HR), femoral blood flow (FBF) and carotid blood flow 
(CBF) in normoxic ( , n=6) or chronic hypoxic ( , n=6) fetuses prior to acute experiments. Significant differences (P<0.05) are: †, differences indicating a 
significant effect of treatment compared with normoxic pregnancy (Student’s t test for unpaired data).  







Figure S1. Hypoxic chambers and the camDAS system. Each chamber contained an electronic 
servo-controlled humidity cool steam injection system to maintain appropriate humidity to the 
inspirate (i). Ambient PO2, PCO2, humidity and temperature within each chamber were monitored via 
sensors (ii). For experimental procedures, each chamber had a double transfer port (iii) to internalise 
material and a manually operated sliding panel (iv) to bring the ewe into a position where daily 
sampling of blood could be achieved through glove compartments (v). Each chamber had a drinking 
bowl on continuous water supply and a rotating food compartment (vi) for determining food intake. A 
sealed transfer isolation cart could be attached to a side exit (vii) to couple chambers together for 
cleaning or for animal movement. Animal waste was collected through an outlet containing a sealing 




valve (viii).  The camDAS system was contained in a custom-made sheep jacket able to hold a 
miniaturized Transonic flow box (ix) on one side, and a pressure box (x) on the other. Cables (xi) 
connected the flow and pressure boxes to two battery packs able to power the system for >24 hours. 
Measurements made using the data acquisition were transmitted wirelessly to a laptop kept outside the 
chamber (xii) via Bluetooth technology (xiii), thereby allowing continuous monitoring of fetal 





Figure S2. Experimental design. The experimental protocol consisted of 5 days (d) of baseline 
recording followed by either chronic normoxia (white bar, n=6) or chronic hypoxia (black bar, n=6, 
%PO2 ~10.5 mmHg). On day 10 of exposure, fetuses received increasing bolus doses of 
phenylephrine (PE; 5, 12.5, 25, 37.5 and 50μg) administered in random order.   The following day, 































































































































Figure S3. Arterial blood gas status during acute hypotension in the chronically hypoxic fetus. 
Values are mean±S.E.M. for arterial pH (A); PaCO2, arterial CO2 partial pressure (B); PaO2, arterial 
O2 partial pressure (C); Sat[Hb], percentage saturation of hemoglobin (D), ABE, Acid-base excess (E) 
and HCO3-, bicarbonate (F) in fetal sheep during acute hypotension in normoxic ( , n=6) or chronic 
hypoxic ( , n=6) pregnancy. The results of the two-way RM ANOVA for main effects and 
interactions are shown.  When a significant (P<0.05) interaction between main effects occurred, 
differences were compared using the Tukey post hoc test. * indicates a significant effect of time 
compared with baseline; † indicates a significant effect of treatment compared with normoxic 
pregnancy. 
 
 
 
